Location History:
- Paris, FR (2016)
- Bailly, FR (2013 - 2020)
- Villepreux, FR (2021 - 2023)
Company Filing History:
6 out of 12 
1 out of 1,745 
1 out of 321 
Years Active: 2013-2023
Title: Hervé Poras: Innovator in Pharmaceutical Chemistry
Introduction
Hervé Poras is a notable inventor based in Bailly, France, recognized for his contributions to pharmaceutical chemistry. With a total of seven patents to his name, he has made significant advancements in the treatment of various medical conditions, particularly those related to nerve pain and ocular inflammation.
Latest Patents
Among his latest patents is a groundbreaking invention concerning amino acid derivatives containing a disulfanyl group. This invention serves as an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain, including migraines and trigeminal neuralgia. The patent details a pharmaceutically acceptable salt of a compound designed to alleviate these painful conditions. Another significant patent involves aminophosphinic derivatives aimed at preventing and treating eye inflammation. This invention focuses on compounds that improve ocular healing and prevent neovascularization, addressing various ocular conditions such as keratitis, scleritis, and glaucoma-related issues.
Career Highlights
Hervé Poras has worked with notable companies in the pharmaceutical sector, including Pharmaleads. His work has been instrumental in developing innovative solutions that address critical health challenges.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Bernard P. Roques and Marie-Claude Fournie-Zaluski, contributing to the advancement of pharmaceutical research and development.
Conclusion
Hervé Poras stands out as a prominent inventor in the field of pharmaceutical chemistry, with a focus on innovative treatments for nerve pain and eye inflammation. His contributions continue to impact the medical community positively.